Bleselumab | m-entrepreneurship.com

Product Name :
Bleselumab

Search keywords :
Bleselumab

drugId :
null

Target Vo:
Tumor necrosis factor receptor superfamily member 5

Target Vo Short Name :
CD40

Moa_Name:
Tumor necrosis factor receptor superfamily member 5 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Kyowa Hakko Kogyo Co Ltd

Active Company_Name :
Astellas Pharma Global Development Inc

Active Indication_Name:
Glomerulosclerosis, Focal Segmental

In Active Indication_Name:
Rejection of organ transplantation

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
EGR1 Antibody
KLF4 Antibody
CXCL10/IP10 Antibody: CXCL10/IP10 Antibody is an unconjugated, approximately 10 kDa, rabbit-derived, anti-CXCL10/IP10 polyclonal antibody. CXCL10/IP10 Antibody can be used for: ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, background without labeling.

Author: Betaine hydrochloride

Related Posts